Bruce Sands, Laurent Peyrin-Biroulet, Edward Loftus, Silvio Danese, Jean-Frédéric Colombel, et al.. Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis.
New England Journal of Medicine, Massachusetts Medical Society, 2019, 381 (13), pp.1215-1226.
⟨10.1056/NEJMoa1905725⟩.
⟨hal-03144487⟩